EP1858535A4 - Compositions a base d'actinidia et modes d'utilisation - Google Patents

Compositions a base d'actinidia et modes d'utilisation

Info

Publication number
EP1858535A4
EP1858535A4 EP06735914A EP06735914A EP1858535A4 EP 1858535 A4 EP1858535 A4 EP 1858535A4 EP 06735914 A EP06735914 A EP 06735914A EP 06735914 A EP06735914 A EP 06735914A EP 1858535 A4 EP1858535 A4 EP 1858535A4
Authority
EP
European Patent Office
Prior art keywords
actinidia
compositions
methods
actinidia compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06735914A
Other languages
German (de)
English (en)
Other versions
EP1858535A2 (fr
Inventor
Julianne Lindemann
George E Stagnitti
Robert H Driver
Mark A Braman
Nancy E Fogg-Johnson
Sunyoung Kim
Mirim Jin
Hyung-Jin Jung
Sung-Seup Shin
Jin-Hwan Oh
Hwa-Jun Lee
Eun-Jin Park
Bongcheol Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EFFICAS, INC.
Pangenomics Co Ltd
Original Assignee
Pangenomics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pangenomics Co Ltd filed Critical Pangenomics Co Ltd
Publication of EP1858535A2 publication Critical patent/EP1858535A2/fr
Publication of EP1858535A4 publication Critical patent/EP1858535A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
EP06735914A 2005-02-25 2006-02-24 Compositions a base d'actinidia et modes d'utilisation Withdrawn EP1858535A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65683905P 2005-02-25 2005-02-25
US65683805P 2005-02-25 2005-02-25
PCT/US2006/006437 WO2006093793A2 (fr) 2005-02-25 2006-02-24 Compositions a base d'actinidia et modes d'utilisation

Publications (2)

Publication Number Publication Date
EP1858535A2 EP1858535A2 (fr) 2007-11-28
EP1858535A4 true EP1858535A4 (fr) 2012-05-02

Family

ID=36941647

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06735914A Withdrawn EP1858535A4 (fr) 2005-02-25 2006-02-24 Compositions a base d'actinidia et modes d'utilisation

Country Status (8)

Country Link
EP (1) EP1858535A4 (fr)
JP (1) JP2008531584A (fr)
AU (1) AU2006218875B2 (fr)
BR (1) BRPI0608042A2 (fr)
MX (1) MX2007010408A (fr)
RU (1) RU2423139C2 (fr)
TW (1) TWI385007B (fr)
WO (1) WO2006093793A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080175888A1 (en) * 2005-02-25 2008-07-24 Julie Lindemann Combination Therapy Comprising Actinidia and Steroids and Uses Thereof
DE102006055210A1 (de) * 2006-11-21 2008-05-29 Ionescu, John G., Dr. Diätisches Lebensmittel mit erhöhter freie Radikale bindender Wirkung
KR101141182B1 (ko) 2009-05-12 2012-05-02 재단법인 제주테크노파크 항염증성 조성물
US9352008B2 (en) 2009-08-12 2016-05-31 Melaleuca, Inc. Dietary supplements and methods for treating pain and inflammation
JP4750202B2 (ja) * 2009-10-16 2011-08-17 株式会社 藍匠 サルナシを用いた健康補助食品の製造方法
ES2634034T5 (es) * 2009-12-29 2020-09-18 Nestle Sa Composiciones nutricionales con copos de fruta que contienen ácido docosahexenoico
JP5688233B2 (ja) * 2010-04-23 2015-03-25 ポーラ化成工業株式会社 Tarc産生抑制剤
JP6179840B2 (ja) * 2011-11-30 2017-08-16 国立大学法人 岡山大学 サルナシ由来の高極性有機溶媒抽出物とその利用
JP6242669B2 (ja) * 2013-11-27 2017-12-06 日本メナード化粧品株式会社 サルナシ抽出物を含有するヒアルロン酸生成促進剤
CN105410588B (zh) * 2015-11-06 2018-05-08 四川兴食尚科技有限公司 一种猕猴桃泡腾片及其制备工艺
WO2019224200A1 (fr) * 2018-05-22 2019-11-28 N.V. Nutricia Biomarqueurs pour améliorer la nutrition des nourrissons à risque
KR102932961B1 (ko) * 2023-11-29 2026-03-20 (주)케이에스코리아 아토피 피부염의 개선 또는 치료용 화장료 조성물 및 그 제조방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022914A1 (en) * 2002-06-07 2004-02-05 Allen Ann De Wees Novel sweetener compositions and methods of use
WO2004017982A1 (fr) * 2002-08-23 2004-03-04 Pangenomics Co., Ltd Composition a base d'extrait d'actinidia arguta et especes connexes, destinee au traitement et a la prevention d'affections allergiques et d'affections non allergiques inflammatoires

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242814A (en) * 1989-10-10 1993-09-07 Eli Lilly And Company Polyether antibiotic
RU2186569C2 (ru) * 1996-01-23 2002-08-10 Ай-Си-Эн ФАРМАСЬЮТИКАЛЗ Модуляция экспрессии тн1/тн2 цитокинов рибавирином и аналогами рибавирина в активированных т-лимфоцитах
US6046185A (en) * 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
DE19758090B4 (de) * 1997-12-18 2008-10-16 Maria Endres Zusammensetzung und deren Verwendung in Kosmetik und Medizin
JP2002302458A (ja) * 2000-12-26 2002-10-18 Takeda Chem Ind Ltd 併用薬
EP1263926B1 (fr) * 2001-03-29 2006-05-17 Council of Scientific and Industrial Research Procede de preparation de vins de plantes a partir de baies himalayennes
US6811796B2 (en) * 2002-04-22 2004-11-02 Matsuura Yakugyo Co., Ltd. Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022914A1 (en) * 2002-06-07 2004-02-05 Allen Ann De Wees Novel sweetener compositions and methods of use
WO2004017982A1 (fr) * 2002-08-23 2004-03-04 Pangenomics Co., Ltd Composition a base d'extrait d'actinidia arguta et especes connexes, destinee au traitement et a la prevention d'affections allergiques et d'affections non allergiques inflammatoires

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KIM YOO KYUNG ET AL: "Anti-inflammation activity of Actinidia polygama", ARCHIVES OF PHARMACAL RESEARCH, NATL. FISHERIES UNIVERSITY, PUSAN, KR, vol. 26, no. 12, 1 December 2003 (2003-12-01), pages 1061 - 1066, XP002528453, ISSN: 0253-6269, DOI: 10.1007/BF02994759 *

Also Published As

Publication number Publication date
WO2006093793A3 (fr) 2006-12-07
JP2008531584A (ja) 2008-08-14
WO2006093793A8 (fr) 2008-03-27
TW200716226A (en) 2007-05-01
AU2006218875B2 (en) 2012-08-09
EP1858535A2 (fr) 2007-11-28
WO2006093793A2 (fr) 2006-09-08
MX2007010408A (es) 2008-03-25
BRPI0608042A2 (pt) 2009-11-03
TWI385007B (zh) 2013-02-11
RU2007135365A (ru) 2009-03-27
AU2006218875A1 (en) 2006-09-08
RU2423139C2 (ru) 2011-07-10

Similar Documents

Publication Publication Date Title
EP1796537A4 (fr) Compositions a base de dendrimeres et procedes d'utilisation de celles-ci
EP1838331A4 (fr) Peptides antimicrobiens et procedes d'utilisation associes
EP1762234A4 (fr) Activateur d'ampk
EP1812102A4 (fr) Endoprothese occlusale et procedes d'utilisation associes
EP1855833A4 (fr) Plasmas et procedes d'utilisation
EP1913112A4 (fr) Agent de soutenement et procedes d'utilisation
EP1851335A4 (fr) Compositions et procédés d'utilisation de mélanges normalisés
EP1831207A4 (fr) Composes d'aminopyrimidine et procedes d'utilisation correspondants
EP1771786A4 (fr) Multitraitement d'echantillons
EP1794372A4 (fr) Attenuateur d'impact
EP1718120A4 (fr) Element d'affichage
EP1706791A4 (fr) Compositions de photoresines et leurs procedes d'utilisation
EP2066817A4 (fr) Commutateurs moléculaires et procédés d'utilisation
EP1722797A4 (fr) Derives d'isoquinoline et methodes d'utilisation
EP1971600A4 (fr) Derives d'isoxasole et leur utilisation
EP2040541A4 (fr) Adjuvants et procédés d'utilisation
EP1874731A4 (fr) Analogues de quinobenzoxazines et procedes d'utilisation de ceux-ci
EP1735456A4 (fr) Compositions poylmeres et procedes associes d'utilisation
EP1827464A4 (fr) Compositions a base de zinc et leurs methodes d'utilisation
EP1954685A4 (fr) Composes furoxane, compositions et procedes d'utilisation
EP1858535A4 (fr) Compositions a base d'actinidia et modes d'utilisation
EP1817055A4 (fr) Compositions d'anticorps anti-ovr110 et methodes d'utilisation correspondantes
EP1701948A4 (fr) Essai d'entactogenes
EP1812012A4 (fr) Inhibiteurs de proteine-tyrosine-phosphatase et methodes d'utilisation de ceux-ci
EP1814977A4 (fr) Compositions a base d'arthrospira et utilisations de celles-ci

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070924

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: EFFICAS, INC.

Owner name: PANGENOMICS CO., LTD.

R17D Deferred search report published (corrected)

Effective date: 20080327

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120403

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/00 20060101AFI20120328BHEP

Ipc: A61P 11/06 20060101ALI20120328BHEP

Ipc: A61P 37/08 20060101ALI20120328BHEP

17Q First examination report despatched

Effective date: 20130411

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130903